ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ARWR Arrowhead Pharmaceuticals Inc

22.14
-2.58 (-10.44%)
11 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Arrowhead Pharmaceuticals Inc NASDAQ:ARWR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.58 -10.44% 22.14 21.45 26.50 25.48 21.79 25.48 2,540,166 05:00:05

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

26/01/2024 10:28pm

Edgar (US Regulatory)



SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No.__)

Filed by the Registrant

Filed by a Party other than the Registrant

Check the appropriate box:
    Preliminary Proxy Statement
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    Definitive Proxy Statement
    Definitive Additional Materials
    Soliciting Material Pursuant to §240.14a-12

ARROWHEAD PHARMACEUTICALS, INC.

image_0.jpg
(Name of Registrant as Specified In Its Charter)
image_1.jpg
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
    No fee required.
    Fee paid previously with preliminary materials
    Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

image_2.jpg

image_17.jpg
image_17.jpg



a0001.jpg



a0002.jpg


1 Year Arrowhead Pharmaceuticals Chart

1 Year Arrowhead Pharmaceuticals Chart

1 Month Arrowhead Pharmaceuticals Chart

1 Month Arrowhead Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock